BioLineRx
Total Raised
$9MInvestors Count
3Deal Terms
2Funding, Valuation & Revenue
2 Fundings
BioLineRx has raised $9M over 2 rounds.
BioLineRx's latest funding round was a IPO for $50M on February 7, 2007.
BioLineRx's latest post-money valuation is from February 2007.
Sign up for a free demo to see BioLineRx's valuations in February 2007 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
2/7/2007 | IPO | $50M | 1 | |||
9/26/2005 | Series A |
Date | 2/7/2007 | 9/26/2005 |
|---|---|---|
Round | IPO | Series A |
Amount | $50M | |
Investors | ||
Valuation | ||
Revenue | ||
Sources | 1 |
BioLineRx Deal Terms
2 Deal Terms
BioLineRx's deal structure is available for 2 funding rounds, including their IPO from February 07, 2007.
Round | IPO | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO | |||||||||||||||
Series A |
BioLineRx Investors
3 Investors
BioLineRx has 3 investors. Pitango invested in BioLineRx's Series A funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
9/26/2005 | 9/26/2005 | 1 Series A | Venture Capital | Israel | ||
Venture Capital | Israel | |||||
Corporation | Israel |
First funding | 9/26/2005 | ||
|---|---|---|---|
Last Funding | 9/26/2005 | ||
Investor | |||
Rounds | 1 Series A | ||
Board Seats | |||
Type | Venture Capital | Venture Capital | Corporation |
Location | Israel | Israel | Israel |
BioLineRx Acquisitions
1 Acquisition
BioLineRx acquired 1 company. Their latest acquisition was Agalimmune on March 23, 2017.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
3/23/2017 | Series A | Acquired | 1 |
Date | 3/23/2017 |
|---|---|
Investment Stage | Series A |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources | 1 |
Compare BioLineRx to Competitors
Aurora Biomed provides automation solutions for the life sciences, drug discovery, and chemical analysis sectors. The company offers products including automated liquid handling systems, nucleic acid extraction systems, and elemental analysis instruments. Aurora Biomed's solutions are used in sectors like genomics, proteomics, forensics, and environmental testing. It was founded in 1998 and is based in Vancouver, British Columbia.
BioCogent is a provider of technology products and services within the personal care and cosmetic industries. The company develops and commercializes biotechnology-based ingredients and offers manufacturing services, research and development, and testing services. It is based in Stony Brook, New York.
BioRegenix is a biotechnology company committed to the development of tissue regeneration technology.
Cellular Engineering Technologies, Inc. provides reagents and human cell lines for the development of cell therapies and regenerative medicines within the biotechnology sector. The company offers products including human recombinant growth factors, cytokines, somatic stem cells, and induced pluripotent stem cells for research and manufacturing purposes. Cellular Engineering Technologies serves the biotechnology and pharmaceutical industries, facilitating drug discovery and IND-enabling activities. It is based in Coralville, Iowa.
Eppendorf is a life science company that specializes in developing and selling laboratory instruments, consumables, and services. The company offers a wide range of products, including pipettes, centrifuges, and ultra-low temperature freezers, designed to facilitate liquid, sample, and cell handling in various laboratory settings. It was founded in 1945 and is based in Hamburg, Germany.
Alice Therapeutics is a biotechnology company.
Loading...